June 12, 2021

We are currently recruiting PhD students (2 openings) and postdoctoral researchers (3 openings). Welcome to apply! [PhD Openings][Postdoc Openings]...... Read More

June 10, 2021

Our two papers are published on Science Immunology and Nature Communications, reporting the identification of monoamine oxidase A (MAO-A) as an immune checkpoint restraining T cell antitumor immunity and modulating tumor-associated macrophage polarization, as well as the potential of repurposing […]...... Read More

May 18, 2021

Dr. Lili Yang receives a $5.9 million CIRM Partnering Opportunity for Translational Research Projects Award to translate a new stem cell-engineered off-the-shelf CAR-iNKT cell therapy for multiple myeloma into clinics. [Link][PDF]...... Read More

May 14, 2021

Our paper is published on Science Immunology, reporting the identification of monoamine oxidase A (MAO-A) as an immune checkpoint restraining antitumor T cell immunity and the repurposing of MAO inhibitor (MAOI) antidepressants for cancer immunotherapy.  Congratulations to all the authors, […]...... Read More

May 11, 2021

Our off-the-shelf cell therapy technology is licensed by a Biotech startup, Appia Bio, for commercial development. The company launches with $52 million Series A financing. [Appia News][Endpoints News]...... Read More

October 18, 2019

Our JEM paper reporting creatine uptake regulation of CD8 T cell immunity is featured on UCLA News and other media. [PDF][UCLA News][UC News][MedicalXpress][ScienceDaily][The Medical News][Technology Networks]...... Read More

October 18, 2019

Our paper reporting creatine uptake regulation of CD8 T cell immunity is published online on the Journal of Experimental Medicine. Congratulations to all the authors, in particular to the co-first authors Stefano Di Biase & Jessie Xiaoya Ma! [Link]...... Read More

October 3, 2019

Our Cell Stem Cell paper reporting HSC-engineered iNKT cell therapy is featured on the journal’s October issue for “In Translation”. [link]...... Read More

September 23, 2019

Our Cell Stem Cell paper reporting HSC-engineering iNKT cell cancer therapy is featured on UCLA News and other media. [PDF][UCLA News][Medical News Today][The Stem Cell Podcast]...... Read More

September 5, 2019

Our paper reporting the development of HSC-engineered iNKT cell therapy for cancer is published online on Cell Stem Cell. Congratulations to all the authors, in particular to the co-first authors Yanni Zhu & Drake Smith! [PDF][Link]...... Read More

August 16, 2019

Our PhD student, Charlie Yanruide Li, receives a Whitecome Predoctoral Fellowship. Congratulations, Charlie!...... Read More

June 11, 2019

Our PhD student, Victor Jiaji Yu, receives a BSCRC Predoctoral Fellowship. Congratulations, Victor!...... Read More

October 22, 2018

Our paper reporting the isolation and characterization of NY-ESO-1-specific T cell receptors is published online on PNAS. This study was in collaboration with the Owen Witte Lab at UCLA and the David Baltimore Lab at Caltech. Congratulations to all the […]...... Read More

May 23, 2018

Our Undergraduate Student, Levina Lin, receives a Dean’s Prize at Research Poster Day 2018. Congratulations, Levina!...... Read More

April 15, 2018

Our two outstanding undergraduate students, Alex Pham and Levina Lin, are both accepted into the UCLA Medical School. Congratulations, Alex and Levina!...... Read More

April 15, 2018

Dr. Jessie Xiao Ma joins us as a postdoc. Welcome, Jessie!...... Read More

February 1, 2018

Dr. Yu Jeong Kim joins us as a postdoc. Welcome, YJ!...... Read More

December 14, 2017

Dr. Lili Yang and Dr. Yu Huang jointly receive a $150,000 BSCRC/CNSI Stem Cell Nano-Medicine Initiative Planning Award from UCLA, to study the in vitro expansion of human blood stem cells using decorated graphene as feeders....... Read More

September 5, 2017

Our paper on miR-146a regulation of Th17 polarization and autoimmunity is published online on the Journal of Clinical Investigation. Congratulations to all the authors, in particular to the co-first authors Bo Li & Shirley Xi Wang! [PDF][Link]...... Read More

September 1, 2017

Our PhD trainee, Dr. Drake Smith, joins the Gilead/Kite Pharma as a Scientist. Congratulations, Drake!...... Read More

July 26, 2017

Our first PhD student, Drake Smith, successfully defended his thesis today. He sets a record of completing a productive PhD training in 4 years. Congratulations, Dr. Smith!...... Read More

July 1, 2017

Our Postdoc trainee, Dr. Inyoung Choi, joins Booz Allen Hamilton as a Senior Consultant. Congratulations, Inyoung!...... Read More

May 1, 2017

Dr. Lili Yang receives the Life Sciences Faculty Excellence Award for Outstanding Research Publication from UCLA....... Read More

January 31, 2017

Dr. Lili Yang receives the Young Investigator Award from the American Association of Immunologist (AAI)....... Read More

September 8, 2016

Our paper on propagating humanized BLT mice for the study of human immunotherapy is published online on the journal of Stem Cells and Development. Congratulations to all the authors, in particular to the first author Drake Smith! [PDF][Link]...... Read More

September 1, 2016

Alice Yang Zhou joins us as a Lab Manager and Research Assistant. Welcome, Alice!...... Read More

July 1, 2016

Dr. Lili Yang receives a $150,000 BSCRC-RHF Research Award from the Rose Hills Foundation (RHF) to study human iNKT cell development....... Read More

May 1, 2016

Our Postdoc trainee, Dr. Bo Li, joins the Loma Linda University as an Assistant Professor. Congratulations, Bo!...... Read More

March 23, 2016

Dr. Lili Yang receives a $7.6M CIRM 2.0 Partnering Opportunity for Translational Research Projects Award to translate a new stem cell-based immunotherapy into clinics. [PDF][Link]...... Read More

September 1, 2015

Our former Lab Manager, Claret Siyuan Liu, joins Amgen as a Scientist. Congratulations, Claret!...... Read More

June 11, 2015

Our PhD Student, Drake Smith, receives a T32 Tumor Immunology Training Grant. Congratulations, Drake!...... Read More

February 1, 2015

Drs. David Baltimore, Owen Witte, and Lili Yang jointly receive a $1M GTSN Challenge Award for Lethal Prostate Cancer from the Prostate Cancer Foundation (PCF), to study T cell receptor gene therapy for treatment of lethal prostate cancer....... Read More

January 20, 2015

Our paper on stem cell-engineered invariant natural killer T (iNKT) cells is published online on PNAS. Congratulations to all the authors, in particular to the first author Drake Smith! [PDF][Link]...... Read More

January 1, 2015

Dr. Lili Yang receives a $150,000 STOP CANCER Research Career Development Award to study tumor immunology and cancer immunotherapy. [PDF][Link]...... Read More

October 9, 2014

Dr. Lili Yang receives a $2.3M NIH Director’s New Innovator (DP2) Award to develop new ways using blood stem cells to attack cancer. [PDF][Link]...... Read More

February 1, 2014

Dr. Lili Yang receives a $50,000 Stem Cell Research Award from the Concern Foundation, to study stem cell-engineered iNKT cell therapy for breast cancer....... Read More

January 1, 2014

Dr. Lili Yang receives a $65,000 SPORE in Prostate Cancer Career Development Award (NIH P50), to study stem cell-engineered iNKT cells for prostate cancer therapy....... Read More

July 1, 2013

Dr. Lili Yang receives a $50,000 BSCRC Innovation Award from UCLA, to study stem cell engineering for immunotherapy....... Read More